
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging role of epigenetic therapies in cutaneous T-cell lymphomas
Jasmine Zain, David Kaminetzky, Owen A. O’Connor
Expert Review of Hematology (2010) Vol. 3, Iss. 2, pp. 187-203
Closed Access | Times Cited: 29
Jasmine Zain, David Kaminetzky, Owen A. O’Connor
Expert Review of Hematology (2010) Vol. 3, Iss. 2, pp. 187-203
Closed Access | Times Cited: 29
Showing 26-50 of 29 citing articles:
RETRACTED: Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors
Md. Ashraful Hoque, Md. Nurul Islam, Md. Shahidul Islam, et al.
Bioorganic & Medicinal Chemistry (2014) Vol. 22, Iss. 15, pp. 3850-3855
Closed Access | Times Cited: 4
Md. Ashraful Hoque, Md. Nurul Islam, Md. Shahidul Islam, et al.
Bioorganic & Medicinal Chemistry (2014) Vol. 22, Iss. 15, pp. 3850-3855
Closed Access | Times Cited: 4
Cutaneous T-Cell Lymphoma
Jasmine Zain, Michael Weichenthal, Scott J. Rodig, et al.
Springer eBooks (2014), pp. 133-167
Closed Access | Times Cited: 2
Jasmine Zain, Michael Weichenthal, Scott J. Rodig, et al.
Springer eBooks (2014), pp. 133-167
Closed Access | Times Cited: 2
Combination Therapy for Cancer: Phototherapy and HDAC Inhibition
Jane Jisun Sung, Tom C. Karagiannis
Springer eBooks (2014), pp. 445-470
Closed Access | Times Cited: 1
Jane Jisun Sung, Tom C. Karagiannis
Springer eBooks (2014), pp. 445-470
Closed Access | Times Cited: 1
Targeting Epigenetic Regulators in Cancer to Overcome Resistance to Targeted Therapy
Mukesh Verma, Vineet Kumar
Resistance to targeted anti-cancer therapeutics (2019), pp. 259-289
Closed Access
Mukesh Verma, Vineet Kumar
Resistance to targeted anti-cancer therapeutics (2019), pp. 259-289
Closed Access